Tag: bispecifics

ASCO News: BioNTech and Pfizer’s bispecifics, and Pazdur — Day 2

Adam Feuerstein/STAT Adam Feuerstein is a senior writer and biotech columnist, reporting on drug development, business, Wall Street,